The double-edged impact of obesity on cancer risk and treatment response: implications for atherosclerosis?
Cardiovasc Res
.
2024 Oct 8:cvae221.
doi: 10.1093/cvr/cvae221.
Online ahead of print.
Authors
Emiel P C van der Vorst
1
2
3
4
,
Mikael Rydén
5
Affiliations
1
Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, 52074 Aachen, Germany.
2
Aachen-Maastricht Institute for CardioRenal Disease (AMICARE), RWTH Aachen University, 52074 Aachen, Germany.
3
Interdisciplinary Center for Clinical Research (IZKF), RWTH Aachen University, 52074 Aachen, Germany.
4
Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University Munich, 80336 Munich, Germany.
5
Department of Medicine (Huddinge), Karolinska Institutet, ME Endokrinologi, Karolinska University Hospital Huddinge, 141 86, Stockholm, Sweden.
PMID:
39376012
DOI:
10.1093/cvr/cvae221
No abstract available
Keywords:
Atherosclerosis; Cancer; Immune-checkpoints; Obesity; PD-1.